Premium Phosphosite-Specific 7TM Antibodies
Novel Tools for Your GPCR Research
Select Your Country of Delivery below

V2 Vasopressin Receptor Antibodies

Close filters
No results were found for the filter!
NEW
Agonist-induced Serine350 phosphorylation of the Vasopressin Receptor 2
pS350-V2 (phospho-Vasopressin Receptor 2 Antibody)
Serine350 (S350) is major phosphorylation site of the Vasopresssin Receptor 2 (V2). The pS350-V2 antibody detects phosphorylation in response to agonists. S350 phosphorylation is likely to be involved in efficient ligand sequestration by...
$ 375.00 *
Details
NEW
Agonist-induced Threonine359/Threonine360 phosphorylation of the Vasopressin Receptor 2.
pT359/pT360-V2 (phospho-Vasopressin Receptor 2...
Threonine359/Threonine360 (T359/T360) is major phosphorylation site of the Vasopressin Receptor 2 (V2). The pT359/pT360-V2 antibody detects phosphorylation in response to agonists. T359/T360 phosphorylation is likely to be involved in...
$ 375.00 *
Details
NEW
Agonist-induced Serine362/Serine363/Serine364 phosphorylation of the Vasopressin Receptor 2
pS362/pS363/pS364-V2 (phospho-Vasopressin...
Serine362/Serine363/Serine364 (S362/S363/S364) is major phosphorylation site of the Vasopresssin Receptor 2 (V2). The pS362/pS363/pS364-V2 antibody detects phosphorylation in response to agonists. S362/S363/S364 phosphorylation is likely...
$ 375.00 *
Details

The V2 receptor displays a high percentage identity with all other AVP/OT receptors. However, unlike the other receptors of the family, V1A, V1B and the OT receptor, it is primarily coupled to Gs, activation of adenylyl cyclase, production of cyclic AMP and activation of protein kinase A. The V2 receptor is secondarily coupled to Gq and a rise in cytosolic free calcium concentration, although with a much lower potency. The V2 receptor is exclusively expressed in the principal cells of the renal collecting duct, being responsible for the antidiuretic effect of AVP. Selective V2 agonists and antagonists have been described. Many natural mutations of the V2 receptor gene result in loss of function receptors leading to the X-linked congenital nephrogenic diabetes insipidus. People suffering from this disease do not concentrate urine and are characterized by polyuria. V2 receptor activity is regulated by phosphorylation of carboxyl-terminal serine350 (pS350-V2), threonine359/threonine360 (pT359/pT360-V2) and serine362/serine363/serine364 (pS362/pS363/pS364-V2). This nomenclature refers to the human V2 receptor. This phosphorylation motif is conserved across species and if highly homologous in mice and rats. For more information on V2 pharmacology please refer to the IUPHAR database. For further reading refer to:

Carter CS, Kenkel WM, MacLean EL, Wilson SR, Perkeybile AM, Yee JR, Ferris CF, Nazarloo HP, Porges SW, Davis JM, Connelly JJ, Kingsbury MA. Is Oxytocin "Nature's Medicine"? Pharmacol Rev. 2020 Oct;72(4):829-861. doi: 10.1124/pr.120.019398. PMID: 32912963; PMCID: PMC7495339.

Bichet D, Bouvier M, Chini B, Gimpl G, Guillon G, Kimura T, Knepper M, Lolait S, Manning M, Mouillac B, O'Carroll AM, Serradeil-Le Gal C, Soloff M, Verbalis JG, Wheatley M, Zingg HH. Vasopressin and oxytocin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database. IUPHAR/BPS Guide to Pharmacology CITE. 2019; 2019(4).

The V2 receptor displays a high percentage identity with all other AVP/OT receptors. However, unlike the other receptors of the family, V1A, V1B and the OT receptor, it is primarily coupled to... read more »
Close window
V2 Vasopressin Receptor Antibodies

The V2 receptor displays a high percentage identity with all other AVP/OT receptors. However, unlike the other receptors of the family, V1A, V1B and the OT receptor, it is primarily coupled to Gs, activation of adenylyl cyclase, production of cyclic AMP and activation of protein kinase A. The V2 receptor is secondarily coupled to Gq and a rise in cytosolic free calcium concentration, although with a much lower potency. The V2 receptor is exclusively expressed in the principal cells of the renal collecting duct, being responsible for the antidiuretic effect of AVP. Selective V2 agonists and antagonists have been described. Many natural mutations of the V2 receptor gene result in loss of function receptors leading to the X-linked congenital nephrogenic diabetes insipidus. People suffering from this disease do not concentrate urine and are characterized by polyuria. V2 receptor activity is regulated by phosphorylation of carboxyl-terminal serine350 (pS350-V2), threonine359/threonine360 (pT359/pT360-V2) and serine362/serine363/serine364 (pS362/pS363/pS364-V2). This nomenclature refers to the human V2 receptor. This phosphorylation motif is conserved across species and if highly homologous in mice and rats. For more information on V2 pharmacology please refer to the IUPHAR database. For further reading refer to:

Carter CS, Kenkel WM, MacLean EL, Wilson SR, Perkeybile AM, Yee JR, Ferris CF, Nazarloo HP, Porges SW, Davis JM, Connelly JJ, Kingsbury MA. Is Oxytocin "Nature's Medicine"? Pharmacol Rev. 2020 Oct;72(4):829-861. doi: 10.1124/pr.120.019398. PMID: 32912963; PMCID: PMC7495339.

Bichet D, Bouvier M, Chini B, Gimpl G, Guillon G, Kimura T, Knepper M, Lolait S, Manning M, Mouillac B, O'Carroll AM, Serradeil-Le Gal C, Soloff M, Verbalis JG, Wheatley M, Zingg HH. Vasopressin and oxytocin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database. IUPHAR/BPS Guide to Pharmacology CITE. 2019; 2019(4).

Recently viewed